Project Grant HT94252510826
Award Date
10/1/25
Completion Date
9/30/28
Dollars Obligated
$1.1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
The U.S. Defense Health Agency awarded a $662,742 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Methodist Hospital Research Institute (HMRI) in Houston, Texas. The grant supports a 3-year research study titled "Home Neuromodulation for Neurogenic Bladder Management in Spinal Cord Injury: A Hybrid Implementation-Efficacy Trial". The research aims to develop and evaluate an innovative home-based neuromodulation system to help manage...
The University of Texas Health Science Center at Houston was awarded a $1,498,514 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program. The grant will fund research from September 2022 through September 2026 to improve functional performance in transfemoral amputees through somatosensory augmentation. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
The University of Texas Health Science Center at Houston (UTHealth) received a $3,845,822 Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to conduct a comparative effectiveness study on transdiagnostic behavior therapy versus treatment-as-usual for adjustment disorder following traumatic event exposure. The award runs from July 1, 2024 to June 30, 2028. The federal grant supports innovative biomedical research initiatives aimed at...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $7,693,599 project grant to the University of Texas Health Science Center at Houston (UTHealth). The award, with a period of performance from Sep 15, 2023 to Sep 14, 2027, will fund research to study "Trauma-Induced Coagulopathy and the Blood-Brain Barrier: Impact of Resuscitation." As the prime grantee, UTHealth will leverage its expertise in biomedical research, clinical...
The University of Texas Health Science Center at Houston (UTHealth) was awarded a $769,578 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "ENHANCING BIOENERGETICS AS A STRATEGY TO IMPROVE OUTCOME AFTER MILD TRAUMATIC BRAIN INJURY". The award, which runs from May 1, 2024 to April 30, 2027, will support UTHealth's efforts to advance scientific knowledge and develop innovative treatments for...
This federal Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) provides $669,421.00 to the University of Texas Health Science Center at Houston (UTHealth) to conduct research on the long-term impact of deployment exposures on neuropathy of brainstem pathways, associated symptoms, and health measures in veterans with Gulf War Illness. The research will be performed over a two-year period from September 30, 2024 to...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $746,972.00 to Texas A&M University to conduct research on "PROTECTING THE INJURED SPINAL CORD: MODULATING AUTONOMIC FUNCTION AFTER SPINAL CORD INJURY (SCI) TO REDUCE TISSUE LOSS AND IMPROVE NEUROLOGICAL OUTCOME". The research seeks to develop new treatments to improve outcomes for individuals with spinal cord injuries by investigating...
The University of Texas Health Science Center at Houston (UTHealth) received a $777,586 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, with a performance period from September 30, 2024 to September 29, 2027, will fund the "Stress Inoculation Training (SIT): An Evidence-Driven, Military-Aligned Psychological Performance and Health Sustainment Prototype" research project. The project...
The University of Washington was awarded a $1,810,550 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 1, 2023 through September 30, 2026 to investigate early chemodenervation of the detrusor muscle to preserve bladder compliance and function over the long term following spinal cord injury. The Military Medical Research and Development program supports basic,...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,560,000.00 to the University of Texas Health Science Center at Houston (UTHealth) to develop drug conjugates of modified LGR4/5/6 ligands for cancer treatment. The funding supports UTHealth's advanced biomedical research focused on transforming healthcare for military service members and the broader public. The award period runs from August 1, 2024...